Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

IMST for Dementia Risk Reduction

NCT: NCT07349706 · RECRUITING

NCT IDNCT07349706
StatusRECRUITING
Start Date2025-11-17
Completion2026-12

Brief Summary

Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST) as a non-pharmacologic intervention to reduce cardiovascular and cognitive risks in older adults. Next, investigators will examine secondary effects of IMST on mood, sleep quality, systemic inflammation, and physical/motor function. Finally, investigators will assess participant adherence and acceptability ratings of using an 8-week home-based IMST protocol in a diverse older adult sample.

Frequently Asked Questions

What is IMST for Dementia Risk Reduction?

IMST for Dementia Risk Reduction is a clinical trial registered under NCT07349706. Current status: RECRUITING.

What is the status of NCT07349706?

The current status of NCT07349706 (IMST for Dementia Risk Reduction) is: RECRUITING.

When did IMST for Dementia Risk Reduction start?

IMST for Dementia Risk Reduction started on 2025-11-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.